132 related articles for article (PubMed ID: 6352005)
21. The pharmacokinetics of prednimustine and chlorambucil in the rat.
Newell DR; Shepherd CR; Harrap KR
Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
[TBL] [Abstract][Full Text] [Related]
22. Value of prednimustine in treating non Hodgkin's lymphomas of favourable histological type.
Klener P; Háber J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):103-8. PubMed ID: 2581855
[TBL] [Abstract][Full Text] [Related]
23. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
J Urol; 1979 Jun; 121(6):763-5. PubMed ID: 458947
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy in metastatic, hormone refractory prostatic cancer using chlorambucil in combination with prednisolone versus conjugate, prednimustine (Leo 1031).
Beckley S; Wajsman LZ; Slack NH; Murphy GP
Urology; 1981 May; 17(5):446-8. PubMed ID: 7015669
[TBL] [Abstract][Full Text] [Related]
25. Prednimustine in adult acute myeloid leukaemia.
Brandt L; Könyves I
Cancer Chemother Pharmacol; 1979; 2(2):133-6. PubMed ID: 394873
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
Gandara DR; Ries CA; Schiff SA; George CB; Lewis JP; Koretz MM; Carter SK
Cancer Chemother Pharmacol; 1982; 9(1):10-2. PubMed ID: 7139848
[TBL] [Abstract][Full Text] [Related]
27. A randomized comparative study of prednimustine and doxorubicin in patients with metastatic breast cancer.
Allegra JC
Semin Oncol; 1986 Mar; 13(1 Suppl 1):42-4. PubMed ID: 3513319
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).
Ehrsson H; Wallin I; Nilsson SO; Johansson B
Eur J Clin Pharmacol; 1983; 24(2):251-3. PubMed ID: 6840176
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
Rankin EM; Harvey C; Knight RK; Rubens RD
Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
[No Abstract] [Full Text] [Related]
30. Premarin priming before prednimustine, high-dose folinic acid and 5-fluorouracil as salvage chemotherapy for advanced breast cancer.
Marini G; Simoncini E; Marpicati P; Montini E; Ferrari V; Arcangeli G; Zaniboni A
Chemioterapia; 1988 Apr; 7(2):130-2. PubMed ID: 2840216
[TBL] [Abstract][Full Text] [Related]
31. Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Samonigg H; Stöger H; Kasparek AK; Schmid M; Dusleag J; Pfeiffer K; Smola M; Steindorfer P; Lechner P
Cancer Chemother Pharmacol; 1991; 27(6):477-80. PubMed ID: 2013118
[TBL] [Abstract][Full Text] [Related]
32. Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study.
Mouridsen HT; Boesen E
Breast Cancer Res Treat; 1983; 3(1):85-9. PubMed ID: 6871484
[TBL] [Abstract][Full Text] [Related]
33. Prednisolone plasma levels after oral administration of Prednimustine. Comparison with levels obtained after administration of an equimolar dose of prednisolone.
Sayed A; Hove WV; Vermeulen A
Oncology; 1981; 38(6):351-5. PubMed ID: 7301281
[TBL] [Abstract][Full Text] [Related]
34. Prednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in Sweden.
Cavallin-Ståhl E; Möller TR
Semin Oncol; 1986 Mar; 13(1 Suppl 1):19-22. PubMed ID: 3952518
[TBL] [Abstract][Full Text] [Related]
35. Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study.
Barnadas A; Mendiola C; Casado A; Villar A; Jimeno J; Clerigue M; Rosell R; Diaz-Rubio E; Cortés-Funes H; García de Paredes M
Eur J Cancer; 1997 Feb; 33(2):312-5. PubMed ID: 9135508
[TBL] [Abstract][Full Text] [Related]
36. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
Catane R; Kaufman J; Mittelman A; Murphy GP
J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
[TBL] [Abstract][Full Text] [Related]
37. [Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
Lutz D; Böhnel J
Osterr Z Onkol; 1977; 3(5-6):155-9. PubMed ID: 323777
[TBL] [Abstract][Full Text] [Related]
38. Preliminary clinical study of prednimustine in lung cancer.
Catane H; Catane R; Takita H; Kaufman JH; Mittelman A; Murphy GP
J Med; 1977; 8(2):115-21. PubMed ID: 268397
[TBL] [Abstract][Full Text] [Related]
39. Combined cytotoxic and endocrine treatment of postmenopausal patients with advanced breast cancer: preliminary results of a phase II study of the combination of prednimustine, novantrone, methotrexate, 5-fluorouracil, and tamoxifen.
Mouridsen HT; Andersson M; Pedersen L
Semin Oncol; 1986 Mar; 13(1 Suppl 1):39-41. PubMed ID: 3952520
[TBL] [Abstract][Full Text] [Related]
40. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
Newell DR; Calvert AH; Harrap KR; McElwain TJ
Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
